APx Acquisition Corp. I reported its financial results for the three and six months ended June 30, 2024, revealing significant changes in its financial position compared to the previous fiscal period. As of June 30, 2024, the company had total assets of $64.95 million, an increase from $62.70 million at the end of 2023. However, total liabilities surged from $1.62 million to $5.75 million, leading to a substantial increase in shareholders' deficit from $(1.62 million) to $(5.75 million).
For the three months ended June 30, 2024, APx Acquisition Corp. reported a net income of $378,011, a notable improvement from a net income of $133,508 in the same period of 2023. This increase was attributed to interest earned on investments in the Trust Account, which rose to $827,424 from $819,171 year-over-year. However, for the six months ended June 30, 2024, the company reported a net loss of $1.87 million, a significant decline compared to a loss of $58,854 in the same period of 2023. The loss was primarily driven by operating costs of $1.49 million and an unrealized loss of $2.02 million related to the change in fair value of warrants.
The company’s cash position remained precarious, with only $168 in cash as of June 30, 2024, down from $8,167 at the end of 2023. The working capital deficit was reported at $2.85 million, indicating liquidity challenges. The company has until December 9, 2024, to complete a business combination, with the possibility of extending this period through additional deposits.
Strategically, APx Acquisition Corp. entered into a Business Combination Agreement with OmnigenicsAI Corp. on March 25, 2024, although the proposed acquisition of MultiplAI Health Ltd. was terminated on August 27, 2024. The company has faced compliance issues with Nasdaq, receiving deficiency letters for failing to file required reports, with a compliance plan due by July 29, 2024.
In terms of financing, the company issued a working capital promissory note for up to $2 million, with an outstanding balance of $1.43 million as of June 30, 2024. The company has incurred significant costs related to its financing and acquisition plans, raising concerns about its ability to continue as a going concern if a business combination is not completed by the deadline.
About APx Acquisition Corp. I
About 10-Q Filings
A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.
Key points about the 10-Q:
- Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
-
Content: It includes:
- Financial statements showing the company's current financial position
- Updates from management on the performance and projections of the business
- Information about potential risks the company faces
- Details on how the company is run internally
- Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.